Zoledronic Acid in the Treatment of Early-Stage Breast Cancer: Is There a Final Verdict?
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zoledronic Acid in the Treatment of Early-Stage Breast Cancer: Is There a Final Verdict?
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 14, Issue 1, Pages 35-43
Publisher
Springer Nature
Online
2011-11-23
DOI
10.1007/s11912-011-0209-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The backbone of progress – preclinical studies and innovations with zoledronic acid
- (2011) Jonathan R. Green et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809
- (2011) C.L. Shapiro et al. EUROPEAN JOURNAL OF CANCER
- Use of Bisphosphonates and Reduced Risk of Colorectal Cancer
- (2011) Gad Rennert et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Bone turnover across the menopause transition
- (2010) Kristy M. Nicks et al. Annals of the New York Academy of Sciences
- Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase
- (2010) Verena Stresing et al. BONE
- Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
- (2010) H L Neville-Webbe et al. BRITISH JOURNAL OF CANCER
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
- (2010) P A Newcomb et al. BRITISH JOURNAL OF CANCER
- Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
- (2010) Rowan T. Chlebowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer
- (2010) Gad Rennert et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: A 5-year follow-up
- (2010) Marjo Tuppurainen et al. MATURITAS
- Potential Anticancer Properties of Bisphosphonates
- (2010) Helen L. Neville-Webbe et al. SEMINARS IN ONCOLOGY
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy
- (2009) Rhys D. Clyburn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Tumor Self-Seeding by Circulating Cancer Cells
- (2009) Mi-Young Kim et al. CELL
- Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results
- (2009) Adam M. Brufsky et al. Clinical Breast Cancer
- Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials
- (2009) M. Gnant CURRENT CANCER DRUG TARGETS
- Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?
- (2009) R.E. Coleman EUROPEAN JOURNAL OF CANCER
- Efficacy and Safety of Denosumab in Postmenopausal Women with Osteopenia or Osteoporosis: A Systematic Review and a Meta-analysis
- (2009) A. D. Anastasilakis et al. HORMONE AND METABOLIC RESEARCH
- Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model
- (2009) Penelope D. Ottewell et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Exploring the anti-tumour activity of bisphosphonates in early breast cancer
- (2008) M.C. Winter et al. CANCER TREATMENT REVIEWS
- Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local Relapse
- (2008) F.-C. Bidard et al. CLINICAL CANCER RESEARCH
- Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo
- (2008) P. D. Ottewell et al. CLINICAL CANCER RESEARCH
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- Aminobisphosphonate-activated γδ T cells in immunotherapy of cancer: doubts no more
- (2008) Nadia Caccamo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Estradiol Rates of Change in Relation to the Final Menstrual Period in a Population-Based Cohort of Women
- (2008) MaryFran R. Sowers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer
- (2008) J. Michael Dixon et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started